Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions
Gardado en:
| Formato: | Electrónico eBook |
|---|---|
| Publicado: |
Marketline
2007
|
| Acceso en liña: | Available in Business Source Ultimate. Ver en el OPAC |
| Etiquetas: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Títulos similares: Lyrica, Botox, Aricept & Hycamtin Case Study: the Benefits of New Drug Application Extensions
- Lyrica Case Study: Building a Successful Drug Launch Strategy
- Topamax, Femara, & Torcetrapib Case Study: Utilizing Usage Extension to Broaden a Drug's Patient Base
- Pfizer Case Study: Protecting Blockbuster Drugs from Generic Competition
- Osteoporosis Drug Reformulation Case Study: Refreshing a Brand Through Reformulation
- GlaxoSmithKline Case Study: Switching Drugs to OTC Status Effectively
- GSK, Wyeth & Forest Laboratories Case Study: Prolonging a Drug's Lifecycle in the Antidepressant Market